Junshi Biosciences 君实生物
9 significant filings since 29 May 2026: 3 on major holder selling, 2 on new listing and 2 on change of interest, and 2 other kinds. The latest, on 31 Aug 2026: 君实生物关于股东减持股份计划的公告.
自 29 May 2026 起有 9 份重大公告：major holder selling 3 份、new listing 2 份、change of interest 2 份，另有 2 类。最新一份（31 Aug 2026）：君实生物关于股东减持股份计划的公告。
The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 10 Sep 2026 | 中邮证券 | 盛丽华 | Outperform 增持 | ▲ | Buy 买入 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 中邮证券 | 盛丽华 | Buy 买入 | 10 Sep 2026 | 3 | — |
| 开源证券 | 余汝意,聂媛媛 | Buy 买入 | 28 Aug 2026 | 2 | — |
| 国金证券 | 甘坛焕 | Buy 买入 | 27 Aug 2026 | 2 | — |
| 中航证券 | 李蔚 | Buy 买入 | 22 Apr 2026 | 1 | — |
| 太平洋 | 周豫,戎晓婕 | Buy 买入 | 17 Apr 2026 | 2 | 53.12 |
| 华安证券 | 谭国超,任婉莹 | Buy 买入 | 31 Oct 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 3 of 11 reports. 每行为该券商近十二个月的最新研报；11 份中 3 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。